Autonomix Medical Statistics
Total Valuation
AMIX has a market cap or net worth of $5.86 million. The enterprise value is -$4.83 million.
Important Dates
The last earnings date was Thursday, February 13, 2025, before market open.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMIX has 2.46 million shares outstanding. The number of shares has increased by 17.62% in one year.
| Current Share Class | 2.46M |
| Shares Outstanding | 2.46M |
| Shares Change (YoY) | +17.62% |
| Shares Change (QoQ) | +62.81% |
| Owned by Insiders (%) | 15.59% |
| Owned by Institutions (%) | 24.98% |
| Float | 2.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.31, with a Debt / Equity ratio of 0.12.
| Current Ratio | 5.31 |
| Quick Ratio | 5.27 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.09 |
Financial Efficiency
Return on equity (ROE) is -662.79% and return on invested capital (ROIC) is -200.57%.
| Return on Equity (ROE) | -662.79% |
| Return on Assets (ROA) | -97.67% |
| Return on Invested Capital (ROIC) | -200.57% |
| Return on Capital Employed (ROCE) | -110.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.70M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -97.00% |
| 50-Day Moving Average | 3.00 |
| 200-Day Moving Average | 14.01 |
| Relative Strength Index (RSI) | 32.88 |
| Average Volume (20 Days) | 50,665 |
Short Selling Information
The latest short interest is 99,738, so 4.05% of the outstanding shares have been sold short.
| Short Interest | 99,738 |
| Short Previous Month | 141,907 |
| Short % of Shares Out | 4.05% |
| Short % of Float | 4.80% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.75M |
| Pretax Income | -15.43M |
| Net Income | -13.63M |
| EBITDA | -10.57M |
| EBIT | -10.75M |
| Earnings Per Share (EPS) | -$12.86 |
Full Income StatementBalance Sheet
The company has $11.82 million in cash and $1.13 million in debt, giving a net cash position of $10.69 million or $4.34 per share.
| Cash & Cash Equivalents | 11.82M |
| Total Debt | 1.13M |
| Net Cash | 10.69M |
| Net Cash Per Share | $4.34 |
| Equity (Book Value) | 9.71M |
| Book Value Per Share | 3.94 |
| Working Capital | 9.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.04 million and capital expenditures -$13,000, giving a free cash flow of -$8.05 million.
| Operating Cash Flow | -8.04M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -8.05M |
| FCF Per Share | -$3.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |